Alexandria Pharmaceuticals

EGX:AXPH Egypt
Market Cap
$154.08K
EGP7.79 Million EGP
Market Cap Rank
#39990 Global
#2 in Egypt
Share Price
EGP806.01
Change (1 day)
+0.76%
52-Week Range
EGP410.33 - EGP912.19
All Time High
EGP912.19
About

Alexandria Pharmaceuticals operates in various business sectors.

Market Cap & Net Worth: Alexandria Pharmaceuticals (AXPH)

Alexandria Pharmaceuticals (EGX:AXPH) has a market capitalization of $154.08K (EGP7.79 Million) as of March 18, 2026. Listed on the EGX stock exchange, this Egypt-based company holds position #39990 globally and #2 in its home market, demonstrating a 0.70% increase in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying Alexandria Pharmaceuticals's stock price EGP806.01 by its total outstanding shares 9665 (9.66K).

Alexandria Pharmaceuticals Market Cap History: 2015 to 2026

Alexandria Pharmaceuticals's market capitalization history from 2015 to 2026. Data shows growth from $4.56K to $154.08K (40.47% CAGR).

Alexandria Pharmaceuticals Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how Alexandria Pharmaceuticals's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.

Latest Price to Sales (P/S) Ratio

No P/S ratio data available

Latest Price to Earnings (P/E) Ratio

No P/E ratio data available

What These Ratios Tell Investors:
  • Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
  • Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
  • Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
  • Industry comparison provides context for whether the company is valued higher or lower than peers.
Year Market Cap (USD) Revenue (USD) Net Income (USD) P/S Ratio P/E Ratio
No financial ratio data available

Competitor Companies of AXPH by Market Capitalization

Companies near Alexandria Pharmaceuticals in the global market cap rankings as of March 18, 2026.

Key companies related to Alexandria Pharmaceuticals by market ranking:

  • LODESTAR BATTERY METALS (F:O4L): Ranked #39981 globally with a market cap of $158.03K USD ( €153.95K EUR).
  • Genesis Electronics Group Inc (PINK:GEGI): Ranked #39982 globally with a market cap of $158.00K USD.
  • Maj Invest Opsparing (CO:MAJOPS): Ranked #39991 globally with a market cap of $157.46K USD ( Dkr1.14 Million DKK).
  • Clarkson (LSE:CKN): Ranked #39992 globally with a market cap of $157.45K USD ( GBX1.29 Billion GBX).

Market capitalization comparison (in billions USD)
Rank Company Symbol Market Cap Price
#39981 LODESTAR BATTERY METALS F:O4L $158.03K €0.00
#39982 Genesis Electronics Group Inc PINK:GEGI $158.00K $0.00
#39991 Maj Invest Opsparing CO:MAJOPS $157.46K Dkr119.90
#39992 Clarkson LSE:CKN $157.45K GBX4665.00

Alexandria Pharmaceuticals Historical Marketcap From 2015 to 2026

Between 2015 and today, Alexandria Pharmaceuticals's market cap moved from $4.56K to $ 154.08K, with a yearly change of 40.47%.

Year Market Cap Change (%)
2026 EGP154.08K +0.70%
2025 EGP153.00K +151.16%
2024 EGP60.92K +78.76%
2023 EGP34.08K +28.46%
2022 EGP26.53K +10.07%
2021 EGP24.10K -7.81%
2020 EGP26.14K +29.01%
2019 EGP20.26K -1.84%
2018 EGP20.65K +66.42%
2017 EGP12.41K +124.08%
2016 EGP5.54K +21.43%
2015 EGP4.56K --

End of Day Market Cap According to Different Sources

On Mar 18th, 2026 the market cap of Alexandria Pharmaceuticals was reported to be:

Source Market Cap
Yahoo Finance $154.08K USD
MoneyControl $154.08K USD
MarketWatch $154.08K USD
marketcap.company $154.08K USD
Reuters $154.08K USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.